Orally administered scallop-derived plasmalogens improve cognitive function in healthy middle-aged and older adults: a randomized, double-blind, placebo-controlled trial
Abstract
Background: Plasmalogens (Pls) are ether phospholipids enriched in the brain that help maintain synaptic integrity and support cognitive function. However, evidence of their cognitive benefits in otherwise healthy individuals remains limited. This randomized, double-blind, placebo-controlled trial examined whether supplementation with scallop-derived Pls (sPls) improves cognitive performance in cognitively healthy Japanese adults aged ≥40 years with below-average verbal memory at baseline.
Methods: Of 168 individuals screened, 68 eligible participants were randomly assigned (1:1) to receive either sPls (1 mg/day) or placebo for 12 weeks. Cognitive performance was assessed using the web-based Cognitrax battery (CNS Vital Signs), with the standardized verbal memory score as the primary outcome. Secondary outcomes included other cognitive domains and plasma brain-derived neurotrophic factor (BDNF) levels. Safety was evaluated through adverse event monitoring and clinical assessments.
Results: Sixty-six participants were included in the analysis. After 12 weeks, standardized verbal memory scores were significantly higher in the sPls group than in the placebo group (estimated marginal mean difference, 10.1; 95% confidence interval, 0.4-19.9; p = 0.042). The sPls group also showed significantly greater improvements in selected attention-related cognitive domains. Plasma BDNF levels increased in both groups, with no significant between-group differences; a modest negative…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 168 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.